Yamamoto, Tokuo

Human Apolipoprotein E Receptor 2

Kim, D.-H., Iijima, H., Goto, K., Sakai, J., Ishii, H., Kim, H.-J., Suzuki, H., Kondo, H., Saeki, S., & Yamamoto, T. (1996) · Journal of Biological Chemistry

Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health

Cited by 384

Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor.

Frykman, P. K., Brown, M. S., Yamamoto, T., Goldstein, J. L., & Herz, J. (1995) · Proceedings of the National Academy of Sciences

Cholesterol and Lipid MetabolismLipid metabolism and disorders

Cited by 256

Virus-mediated Transduction of Apolipoprotein E (ApoE)-Sendai Develops Lipoprotein Glomerulopathy in ApoE-deficient Mice

Ishigaki, Y., Oikawa, S., Suzuki, T., Usui, S., Magoori, K., Kim, D.-H., Suzuki, H., Sasaki, J., Sasano, H., Okazaki, M., et al. (2000) · Journal of Biological Chemistry

Lipid metabolism and disordersRenal Diseases and Glomerulopathies

Cited by 58

Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy

Saito, T., Ishigaki, Y., Oikawa, S., & Yamamoto, T. T. (2002) · Trends in Cardiovascular Medicine

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 25

Role of apolipoprotein E variants in lipoprotein glomerulopathy and other renal lipidoses

Saito, T., Ishigaki, Y., Oikawa, S., & Yamamoto, T. T. (2001) · Clinical and Experimental Nephrology

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 18